rs759350875
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_000426.4(LAMA2):c.5518G>A(p.Asp1840Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000992 in 1,612,736 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000426.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital merosin-deficient muscular dystrophy 1AInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
- LAMA2-related muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- muscular dystrophy, limb-girdle, autosomal recessive 23Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000426.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LAMA2 | NM_000426.4 | MANE Select | c.5518G>A | p.Asp1840Asn | missense | Exon 38 of 65 | NP_000417.3 | ||
| LAMA2 | NM_001079823.2 | c.5518G>A | p.Asp1840Asn | missense | Exon 38 of 64 | NP_001073291.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LAMA2 | ENST00000421865.3 | TSL:5 MANE Select | c.5518G>A | p.Asp1840Asn | missense | Exon 38 of 65 | ENSP00000400365.2 | ||
| LAMA2 | ENST00000618192.5 | TSL:5 | c.5782G>A | p.Asp1928Asn | missense | Exon 39 of 66 | ENSP00000480802.2 | ||
| LAMA2 | ENST00000617695.5 | TSL:5 | c.5518G>A | p.Asp1840Asn | missense | Exon 38 of 64 | ENSP00000481744.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000359 AC: 9AN: 250892 AF XY: 0.0000443 show subpopulations
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1460552Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 726672 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74344 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
Inborn genetic diseases Uncertain:1
The c.5518G>A (p.D1840N) alteration is located in exon 38 (coding exon 38) of the LAMA2 gene. This alteration results from a G to A substitution at nucleotide position 5518, causing the aspartic acid (D) at amino acid position 1840 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
LAMA2-related muscular dystrophy Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at